TW202019476A - 伴隨視網膜纖維化之眼部疾病之藥劑 - Google Patents

伴隨視網膜纖維化之眼部疾病之藥劑 Download PDF

Info

Publication number
TW202019476A
TW202019476A TW108126291A TW108126291A TW202019476A TW 202019476 A TW202019476 A TW 202019476A TW 108126291 A TW108126291 A TW 108126291A TW 108126291 A TW108126291 A TW 108126291A TW 202019476 A TW202019476 A TW 202019476A
Authority
TW
Taiwan
Prior art keywords
antibody
vegf
amino acid
antigen
acid sequence
Prior art date
Application number
TW108126291A
Other languages
English (en)
Chinese (zh)
Inventor
柴垣圭一
馬克 Ｃ 吉利斯
維勇 申
金忠 張
Original Assignee
日商參天製藥股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商參天製藥股份有限公司 filed Critical 日商參天製藥股份有限公司
Publication of TW202019476A publication Critical patent/TW202019476A/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
TW108126291A 2018-07-26 2019-07-25 伴隨視網膜纖維化之眼部疾病之藥劑 TW202019476A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862703676P 2018-07-26 2018-07-26
US62/703,676 2018-07-26

Publications (1)

Publication Number Publication Date
TW202019476A true TW202019476A (zh) 2020-06-01

Family

ID=69180495

Family Applications (1)

Application Number Title Priority Date Filing Date
TW108126291A TW202019476A (zh) 2018-07-26 2019-07-25 伴隨視網膜纖維化之眼部疾病之藥劑

Country Status (2)

Country Link
TW (1) TW202019476A (ja)
WO (1) WO2020022438A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114181972A (zh) * 2021-11-23 2022-03-15 上海本导基因技术有限公司 适用于难治性血管新生性眼疾病基因治疗的慢病毒载体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2467156B1 (en) * 2009-08-17 2017-11-01 Tracon Pharmaceuticals, Inc. Combination therapy of cancer with anti-endoglin antibodies and anti-vegf agents
KR20220013459A (ko) * 2013-10-25 2022-02-04 악셀레론 파마 인코포레이티드 섬유화 질환을 치료하기 위한 엔도글린 펩티드
US10155820B2 (en) * 2014-11-12 2018-12-18 Tracon Pharmaceuticals, Inc. Anti-endoglin antibodies and uses thereof

Also Published As

Publication number Publication date
WO2020022438A8 (ja) 2020-03-05
WO2020022438A1 (ja) 2020-01-30

Similar Documents

Publication Publication Date Title
JP6941148B2 (ja) 補体成分ｃ５抗体
US20180353614A1 (en) VE-PTP Extracellular Domain Antibodies Delivered by a Gene Therapy Vector
US11958905B2 (en) Fusion proteins containing a BDNF and an anti-human transferrin receptor antibody
KR101482483B1 (ko) 인간 단백질 타이로신 포스파타아제 베타(ｈｐｔｐ베타)에 결합하는 항체 및 그의 용도
JP6669882B2 (ja) 抗−ｃ−ＭＥＴ抗体及びその用途
KR20170087950A (ko) 혈관성 안 질환을 치료하기 위한 방법 및 제형
US9493554B2 (en) Methods of treating retinal disorders with anti-apelin antibodies
MX2014004449A (es) Tratamiento de enfermedad ocular.
KR20190031246A (ko) VE-PTP (HPTP-β)를 표적으로 하는 인간화된 단클론성 항체
US11666659B2 (en) Monoclonal antibody specifically binding to human plasmalemma vesicle-associated protein PV-1, preparation and use thereof
JP7390317B2 (ja) 抗Ｔｉｅ２抗体およびその使用
KR102497171B1 (ko) 항-안지오포이에틴-2(Ang2) 항체 및 그의 용도
CN117467025B (zh) 一种抗vegf和补体双功能融合蛋白及其应用
TW202019476A (zh) 伴隨視網膜纖維化之眼部疾病之藥劑
JP7075135B2 (ja) 増殖因子を標的とする二機能性分子を使用したがんの治療方法
AU2021304993B2 (en) Fusion protein including complement pathway inhibitor and angiogenesis inhibitor and use thereof
WO2022086501A1 (en) Methods and compositions for treating ocular vascular disorders
CN113645994A (zh) 使用色素上皮衍生因子(pedf)治疗疾病的方法
US20220056120A1 (en) Methods of treating ocular pathologies using bifunctional molecules that target growth factors
RU2776850C2 (ru) Способы лечения глазных заболеваний
KR20220069076A (ko) 항-nrp1a 항체와 안구 또는 안구 질환 치료를 위한 이의 용도
WO2007110209A1 (en) Biological materials and uses thereof